China Colorectal Cancer Screening 1 (C-Cost1)
Official title: China Colorectal Cancer Screening Trial 1 (C-Cost1): Colonoscopy Versus FIT Versus FIT Plus Blood Test in the Average Risk Population
Run by Zhejiang University · NCT07090291 · Data updated 2026-11-12
This project will test whether one-time colonoscopy, annual FIT, or annual FIT plus a blood cfDNA methylation test best detects colorectal cancer and advanced adenomas in average-risk adults aged 45–74 in China.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 74 Years |
| Sex | All |
| Enrollment | 60300 (estimated) |
| Sponsor | Zhejiang University Academic / other |
| Locations | 7 sites (Guandong and 6 other locations) |
| Status | Recruiting |
| Started | August 8, 2025 |
| Main results expected | July 2035 |
| Study ends | July 2035 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT07090291 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 45–74 years old in generally good health, without prior colorectal cancer or recent colorectal examinations, who are at average risk and can provide informed consent.
✕Probably not a fit
People with a personal history of colorectal cancer or precancerous lesions, recent colonoscopy or stool/DNA/cfDNA testing, current cancer treatment, urgent GI symptoms, or severe comorbidities unlikely to tolerate screening are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a large cluster-randomized trial in China enrolling at least 60,300 average-risk adults aged 45–74 and randomizing clusters to three screening strategies. One arm receives a one-time colonoscopy at baseline, the second receives annual fecal immunochemical tests (FIT) for four years with colonoscopy if FIT-positive, and the third combines annual FIT with a blood-based cfDNA methylation test. Fecal, blood, and tissue samples will be collected, suspicious lesions resected and pathologically examined, and all participants will be followed annually during a 4-year screening phase and then long-term. The trial aims to compare detection rates of colorectal cancer and advanced adenomas and inform screening approaches for the average-risk population in China.
Why it matters
Potential benefit: If successful, the trial could identify a more sensitive and feasible screening approach that detects cancers and precancerous lesions earlier, potentially reducing colorectal cancer deaths and treatment burden.
How similar studies have gone: Colonoscopy and FIT are established screening methods with demonstrated effectiveness, while blood-based cfDNA methylation tests are promising and have shown encouraging but still emerging results in early detection studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age: 45-74 years old; 2. In good general condition, with normal mental state and voluntarily signing the informed consent form; Exclusion Criteria: 1. Personal history of colorectal cancer or precancerous lesions; 2. History of previous colonrectal resection surgery; 3. Diagnosed with cancer before enrollment or currently receiving any cancer-related treatment; 4. Having received colonoscopy, flexible sigmoidoscopy, CT colonography and other examinations within the past 5 years; 5. Having received FIT or FIT-sDNA or cfDNA test within the past 1 year; 6. Symptomatic lower gastrointestinal diseases or symptoms suggesting the need for diagnostic colonoscopy for confirmation; 7. Accompanied by severe diseases that are not suitable for colorectal cancer screening;
Where it's running
-
Sun Yat-sen University Cancer Center
Guandong, China Recruiting -
Maoming People's Hospital
Guangdong, China Recruiting -
The Fourth Hospital of Hebei Medical University
Hebei, China Recruiting -
Nanjing Medical University
Nanjing, China Recruiting -
Shanghai Municipal Center For Disease Control & Prevention
Shanghai, China Recruiting -
Sichuan Cancer Hospital & Institute, Sichuan Cancer Center
Sichuan, China Recruiting
Show 1 more location
-
Zhejiang Provincial Center for Disease Control and Prevention
Zhejiang, China Recruiting
Study contacts
- Study coordinator: Kefeng Ding, MD
- Email: dingkefeng@zju.edu.cn
- Phone: 86-571-87784827
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multi-omics approach for early detection of colorectal cancer
This study is testing a new way to spot colorectal cancer early by looking at blood samples from people with cancer and healthy individuals to see if certain markers can help predict the disease.
-
New oral synbiotic formula to reduce colorectal adenoma recurrence
This study is testing a new oral formula made of probiotics and prebiotics to see if it can help prevent the return of certain growths in the colon after they've been removed.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.